238 related articles for article (PubMed ID: 26195751)
1. Preventing clonal evolutionary processes in cancer: Insights from mathematical models.
Rodriguez-Brenes IA; Wodarz D
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):8843-50. PubMed ID: 26195751
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution models of tumor heterogeneity.
Shlush LI; Hershkovitz D
Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
[TBL] [Abstract][Full Text] [Related]
3. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
Olbertova H; Plevova K; Pavlova S; Malcikova J; Kotaskova J; Stranska K; Spunarova M; Trbusek M; Navrkalova V; Dvorackova B; Tom N; Pal K; Jarosova M; Brychtova Y; Panovska A; Doubek M; Pospisilova S
BMC Cancer; 2022 Feb; 22(1):137. PubMed ID: 35114947
[TBL] [Abstract][Full Text] [Related]
4. Moderate stem-cell telomere shortening rate postpones cancer onset in a stochastic model.
Holbek S; Bendtsen KM; Juul J
Phys Rev E Stat Nonlin Soft Matter Phys; 2013 Oct; 88(4):042706. PubMed ID: 24229212
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.
Risques RA; Lai LA; Himmetoglu C; Ebaee A; Li L; Feng Z; Bronner MP; Al-Lahham B; Kowdley KV; Lindor KD; Rabinovitch PS; Brentnall TA
Cancer Res; 2011 Mar; 71(5):1669-79. PubMed ID: 21363920
[TBL] [Abstract][Full Text] [Related]
6. Modeling Tumor Clonal Evolution for Drug Combinations Design.
Zhao B; Hemann MT; Lauffenburger DA
Trends Cancer; 2016 Mar; 2(3):144-158. PubMed ID: 28435907
[TBL] [Abstract][Full Text] [Related]
7. Harnessing Tumor Evolution to Circumvent Resistance.
Pogrebniak KL; Curtis C
Trends Genet; 2018 Aug; 34(8):639-651. PubMed ID: 29903534
[TBL] [Abstract][Full Text] [Related]
8. Stochastic Telomere Shortening and the Route to Limitless Replicative Potential.
Ye Y; Yang Z; Lei J
J Comput Biol; 2019 Apr; 26(4):350-363. PubMed ID: 30762424
[TBL] [Abstract][Full Text] [Related]
9. A stochastic model of cell replicative senescence based on telomere shortening, oxidative stress, and somatic mutations in nuclear and mitochondrial DNA.
Sozou PD; Kirkwood TB
J Theor Biol; 2001 Dec; 213(4):573-86. PubMed ID: 11742526
[TBL] [Abstract][Full Text] [Related]
10. Exploiting evolutionary steering to induce collateral drug sensitivity in cancer.
Acar A; Nichol D; Fernandez-Mateos J; Cresswell GD; Barozzi I; Hong SP; Trahearn N; Spiteri I; Stubbs M; Burke R; Stewart A; Caravagna G; Werner B; Vlachogiannis G; Maley CC; Magnani L; Valeri N; Banerji U; Sottoriva A
Nat Commun; 2020 Apr; 11(1):1923. PubMed ID: 32317663
[TBL] [Abstract][Full Text] [Related]
11. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.
Landau DA; Sun C; Rosebrock D; Herman SEM; Fein J; Sivina M; Underbayev C; Liu D; Hoellenriegel J; Ravichandran S; Farooqui MZH; Zhang W; Cibulskis C; Zviran A; Neuberg DS; Livitz D; Bozic I; Leshchiner I; Getz G; Burger JA; Wiestner A; Wu CJ
Nat Commun; 2017 Dec; 8(1):2185. PubMed ID: 29259203
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.
Bowman RL; Busque L; Levine RL
Cell Stem Cell; 2018 Feb; 22(2):157-170. PubMed ID: 29395053
[TBL] [Abstract][Full Text] [Related]
13. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
Condoluci A; Rossi D
J Natl Compr Canc Netw; 2020 Dec; 19(2):227-233. PubMed ID: 33383567
[TBL] [Abstract][Full Text] [Related]
14. Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia.
Rozhok AI; Salstrom JL; DeGregori J
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1050-5. PubMed ID: 26755588
[TBL] [Abstract][Full Text] [Related]
15. Alternative strategies for optimizing treatment of chronic lymphocytic leukemia with complex clonal architecture.
Smith MR; Cronin JF; Weiss RF
Leuk Res; 2021 Nov; 110():106663. PubMed ID: 34304129
[TBL] [Abstract][Full Text] [Related]
16. Spatial Measures of Genetic Heterogeneity During Carcinogenesis.
Storey K; Ryser MD; Leder K; Foo J
Bull Math Biol; 2017 Feb; 79(2):237-276. PubMed ID: 27905065
[TBL] [Abstract][Full Text] [Related]
17. Drug-Resistant Cancer Treatment Strategies Based on the Dynamics of Clonal Evolution and PKPD Modeling of Drug Combinations.
Vakil V; Trappe W
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(3):1603-1614. PubMed ID: 33326383
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.
Zapatka M; Tausch E; Öztürk S; Yosifov DY; Seiffert M; Zenz T; Schneider C; Blöhdorn J; Döhner H; Mertens D; Lichter P; Stilgenbauer S
Haematologica; 2022 Mar; 107(3):604-614. PubMed ID: 33691380
[TBL] [Abstract][Full Text] [Related]
19. Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.
Jebaraj BMC; Tausch E; Landau DA; Bahlo J; Robrecht S; Taylor-Weiner AN; Bloehdorn J; Scheffold A; Mertens D; Böttcher S; Kneba M; Jäger U; Zenz T; Wenger MK; Fingerle-Rowson G; Wendtner C; Fink AM; Wu CJ; Eichhorst B; Fischer K; Hallek M; Döhner H; Stilgenbauer S
Leukemia; 2019 Sep; 33(9):2183-2194. PubMed ID: 30911113
[TBL] [Abstract][Full Text] [Related]
20. Examples of mathematical modeling: tales from the crypt.
Johnston MD; Edwards CM; Bodmer WF; Maini PK; Chapman SJ
Cell Cycle; 2007 Sep; 6(17):2106-12. PubMed ID: 17873520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
